Jump to content
  • Member Statistics

    • Total Members
      1,133
    • Most Online
      325

    Newest Member
    MNelson
    Joined
  • Posts

    • Prevalence of gastrointestinal comorbidities in rosacea: Comparison of subantimicrobial, modified release doxycycline versus conventional release doxycycline. J Am Acad Dermatol. 2018 Feb;78(2):417-419 Authors: Lim HG, Fischer A, Rueda MJ, Kendall J, Kang S, Chien AL PMID: 29332715 [PubMed - in process] {url} = URL to article
    • crawfish18 (at RF) reports mixing zinc oxide 20% and Sulfur 10% in a 50/50% mix which crawfish18 says works for rosacea. 
    • Related Articles Inate immunity in rosacea. Langerhans cells, plasmacytoid dentritic cells, Toll-like receptors and inducible oxide nitric synthase (iNOS) expression in skin specimens: case-control study. Arch Dermatol Res. 2018 Jan 12;: Authors: Moura AKA, Guedes F, Rivitti-Machado MC, Sotto MN Abstract
      Rosacea is a chronic inflammatory condition with predominant facial involvement. Because of that, many patients sense that rosacea affects quality of life. The etiology of rosacea remains unknown. Recent studies have suggested that aberrant innate immunity is central to this disease. The aim of this study was to examine the presence of Langerhans cells, plasmacytoid dentritic cells (PDC), the expression of Toll-like receptors (TLR) and inducible oxide nitric synthase (iNOS) in skin of patients with rosacea, to highlight the participation of innate immunity in its pathogenesis. 28 biopsy specimens were taken from patients with clinical and histopathological findings of rosacea. Immunohistochemical demonstration of Langerhans cells (anti-CD1a antibody), PDC (anti-CD 123 antibody), TLR2, TLR4 and iNOS was performed in skin samples and compared with normal skin controls. The expression of Langerhans cells was lower in rosacea group than in control group. PDC were found in skin samples of rosacea as isolated cells and forming small clusters. Expression of TLR2, TLR4 and iNOS was higher in rosacea samples than in normal skin controls. This research demonstrates early and late stage components of innate immunity in specimens of rosacea ratifying the existence of an altered innate immunity in its pathogenesis.
      PMID: 29330632 [PubMed - as supplied by publisher] {url} = URL to article
    • Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial. J Drugs Dermatol. 2018 Jan 01;17(1):97-105 Authors: Kircik LH, DuBois J, Draelos ZD, Werschler P, Grande K, Cook-Bolden FE, Weng E, Berk DR, Ahluwalia G Abstract
      An unmet need exists for a safe, tolerable, effective treatment for moderate to severe persistent facial erythema in patients with rosacea. This pivotal phase 3, multicenter, double-blind study evaluated the efficacy and safety of topical oxymetazoline in patients with facial erythema associated with moderate to severe rosacea. Patients were randomly assigned to treatment with oxymetazoline hydrochloride cream 1.0% or vehicle applied once daily for 29 days, and were followed for 28 days posttreatment. The primary efficacy outcome was having at least a 2-grade decrease from baseline on both the Clinician Erythema Assessment (CEA) and the Subject Self-Assessment for rosacea facial redness (SSA) scales (composite success) at 3, 6, 9, and 12 hours postdose on day 29. Safety assessments included treatment-emergent adverse events (TEAEs) and posttreatment worsening of erythema (composite CEA/SSA increase of 1-grade severity from baseline; rebound effect). A total of 440 patients (mean age, 49.5 years; 78.9% females) were randomized (oxymetazoline, n=222; vehicle, n=218); most had moderate erythema. On day 29, significantly greater proportions of oxymetazoline recipients achieved the primary efficacy outcome at each time point (P less than 0.02) and overall (P less than 0.001) compared with vehicle recipients. The incidence of discontinuation due to TEAEs was low in both groups (oxymetazoline group, 1.8%; vehicle group, 0.5%). The most common TEAEs reported during the entire study period were application-site dermatitis, application-site erythema, and headache in the oxymetazoline group (1.4% each), and headache (0.9%) in the vehicle group. Following cessation of treatment, low proportions of patients experienced rebound effect (oxymetazoline group, 2.2%; vehicle group, 1.1%). Oxymetazoline applied to the face once daily for 29 days was effective, safe, and well tolerated in patients with moderate to severe persistent facial erythema of rosacea. <p><em>J Drugs Dermatol. 2018;17(1):97-105.</em></p>.
      PMID: 29320594 [PubMed - in process] {url} = URL to article
    • Patients' self-esteem before and after chemical peeling procedure. J Cosmet Laser Ther. 2017 Dec 29;:1-3 Authors: Anargyros K, Eftychia P, Christos C, Vasiliki E, Vasiliki M, Kaliopi A, Irene P, Dimitrios R, George K Abstract
      INTRODUCTION: Chemical peeling is a safe method, widely used to treat a variety of skin conditions and reduce the aging effects. This study aims to evaluate self-esteem among adolescents who undergo chemical peelings.
      MATERIAL AND METHODS: One hundred and twenty six patients constituted the study group. Sixty seven individuals had undergone chemical peeling for therapeutic reasons and 59 individuals for cosmetic reasons. To assess patients' self-esteem, the Rosenberg's Self-esteem Scale (RSES) was used before and after treatment. The control group included 71 healthy, age- and sex-matched volunteers from the general population. They were also asked to complete the RSES, after the same time interval as the patients.
      RESULTS: The healthy controls (23.01 ± 3.12) presented statistically significantly higher self-esteem than both the groups of individuals who would be submitted to chemical peeling. Furthermore, patients who would undergo peeling for therapeutic reasons (21.58 ± 3.20) had statistically significantly higher self-esteem than those who would undergo the procedure for cosmetic reasons (18.97 ± 3.36). After the chemical peeling sessions, the self-esteem of patients treated for therapeutic reasons (23.48 ± 2.43) and of patients treated for cosmetic reasons (22.83 ± 3.34) improved statistically significantly, while the self-esteem of the healthy controls remained stable, as expected.
      CONCLUSION: Patients who undergo chemical peelings tend to have low levels of self-esteem. Although facial lesions in skin diseases such as acne, acne scars, rosacea, and melasma seem to have negative effect on individuals' self-consciousness, patients who would be submitted to chemical peeling in order to treat wrinkles, loss of radiance, and skin tone clarity have even lower self-esteem. Chemical peelings were shown to favorably affect patient's self-esteem since all patients showed an increase in self-esteem after treatment, while the control group experienced no change.
      PMID: 29286838 [PubMed - as supplied by publisher] {url} = URL to article
    • Demodex and rosacea: Is there a relationship? Indian J Ophthalmol. 2018 Jan;66(1):36-38 Authors: Gonzalez-Hinojosa D, Jaime-Villalonga A, Aguilar-Montes G, Lammoglia-Ordiales L Abstract
      PURPOSE: The objective of the study is to compare the frequency of Demodex on the eyelash follicle of patients with rosacea and referents without rosacea or ophthalmological disorders.
      METHODS: This is a comparative, open, observational, and cross-sectional study that included 41 patients diagnosed with rosacea and 41 referents without rosacea diagnosis or ophthalmic alterations. The individuals underwent a slit-lamp examination in which two eyelashes per eyelid were removed with fine forceps. The presence of Demodex was sought by direct visualization under a light microscope. The results were expressed as "positive" when at least one mite on one lash was found and "negative" when no mite was identified. Chi-square test was used to compare the presence of mites in both groups.
      RESULTS: Eighty-two study individuals (45 females and 37 males) were included, of which 41 patients were diagnosed with rosacea and 41 were without rosacea or ophthalmic alterations. The average mean age was 37 years with a minimum of 19 and a maximum of 87 years. Of the 41 patients with rosacea, 31 had erythematotelangiectatic rosacea and 10 had papulopustular rosacea. There were no patients with phymatous or ocular rosacea. The presence of Demodex was found in 32 patients: 24 patients with rosacea diagnosis (16 of the erythematotelangiectatic subtype and 8 of papulopustular subtype) and 8 patients without rosacea or ophthalmic alterations (P ≤ 0.001).
      CONCLUSION: Rosacea was found to be a statistically significant risk factor for Demodex infestation in eyelashes, irrespective of age and sex, with a higher prevalence in papulopustular variety.
      PMID: 29283119 [PubMed - in process] {url} = URL to article
    • Characterization of the facial microbiome in twins discordant for rosacea. Exp Dermatol. 2017 Dec 28;: Authors: Zaidi AK, Spaunhurst K, Sprockett D, Thomason Y, Mann MW, Fu P, Ammons C, Gerstenblith M, Tuttle MS, Popkin DL Abstract
      Previously, we determined that genetic and environmental factors contributed equally towards rosacea in twins. To assess an environmental factor, we characterized the malar cheek bacterial microbiome from twins discordant for rosacea. We found no significant difference in facial microbiome alpha and beta diversity between related twins discordant for rosacea. However, the relative percentage abundance of Gordonia and Geobacillus, low abundant genera, was positively and negatively associated with rosacea severity, respectively. Our data demonstrate a significant correlation between facial microbiome and severity of rosacea in genetically matched twins and importantly that overall microbiome composition is largely unchanged. This article is protected by copyright. All rights reserved.
      PMID: 29283459 [PubMed - as supplied by publisher] {url} = URL to article
    • But dermatologists are highly against using the tools at home because they say the needles aren’t big enough to penetrate the proper holes into skin, so you’re essentially damaging your face for no reason. And without proper sterilization, derma rollers can harbor harmful bacteria causing infections, breakouts and can trigger skin conditions such as rosacea, which causes redness and bumps on the face; eczema, itchy inflammation spots; and melasma, brown patches on the skin. Derma Rollers are hot sellers, but the at-home microneedling tool can sometimes do more harm than good, by Jeanette Settembre, Moneyish
    • "Shauna Willetts, 24, was diagnosed with rosacea by a dermatologist two years ago. “My first winter living in New York City, I woke up one morning and my face was covered in red, irritated, puss-filled spots,” she tells SELF. “I've always had acne, but this was something I hadn't experienced before, and it took quite the toll on my confidence"....In these cases, some people with rosacea turn to makeup, in addition to prescription creams, to cover and treat the visible signs of a flare-up." How to Cover Up Redness With Makeup, by Jessica Cruel, SELF Forum Category > Cosmetics RRDi Store > Cosmetics
    • Rosacea. Tidsskr Nor Laegeforen. 2017 10 03;137(18): Authors: Huldt-Nystrøm T, Danielsen K, Li X, Stangeland KZ PMID: 28972327 [PubMed - indexed for MEDLINE] {url} = URL to article
    • "Researchers found that the risk for rosacea, as well as other skin disorders, such as atopic eczema and onychomycosis (toenail fungus), increased with the presence of systemic low-grade inflammation." Study Finds Association Between Low-Grade Inflammation and Rosacea, Samantha DiGrande, AJMC
    • Combination of platelet rich plasma in fractional carbon dioxide laser treatment increased clinical efficacy of for acne scar by enhancement of collagen production and modulation of laser-induced inflammation. Lasers Surg Med. 2017 Dec 20;: Authors: Min S, Yoon JY, Park SY, Moon J, Kwon HH, Suh DH Abstract
      BACKGROUND: Platelet-rich plasma (PRP) which contains large amounts of growth factors has been tried to enhance therapeutic efficacy of laser treatment for acne scar with unknown underlying mechanism.
      OBJECTIVES: The present study was conducted to investigate the molecular mechanism of increased clinical efficacy of PRP when combined with fractional laser treatment for treating acne scars.
      METHODS: Subjects with mild to moderate acne scars were treated with two sessions of fractional CO2 laser therapy given with and without co-administration of PRP. Skin biopsy specimens were obtained at baseline, 1, 3, 7, and 28 days for investigation of molecular profiles associated with skin changes produced by laser plus PRP treatment.
      RESULTS: The PRP treatment increased clinical efficacy with decreased severity of adverse effects such as erythema, swelling and oozing. Productions of TGFβ1 and TGFβ3 proteins were more highly elevated on the PRP-treated side of the face compared to the control side at day 28. Furthermore, PRP-treated side showed significant increase of c-myc, TIMP, and HGF expression. Experimental fibroblast culture model was also used. PRP administration after laser irradiation increased expressions of p-Akt, TGFβ1, TGFβ3, β-catenin, collagen 1, and collagen 3 in both dose-dependent and time dependent manners in fibroblast. Moreover, we acquired clinical and histological data through randomized control clinical trial.
      CONCLUSION: Taken together with human study results combined with the data from cell experiments we suggest that PRP treatment increased fibrogenetic molecules induced by fractional CO2 laser, which have association with clinical effect. Lasers Surg. Med. © 2017 Wiley Periodicals, Inc.
      PMID: 29266290 [PubMed - as supplied by publisher] {url} = URL to article
    • An unusual presentation of ocular rosacea. Arq Bras Oftalmol. 2017 Nov-Dec;80(6):396-398 Authors: Celiker H, Toker E, Ergun T, Cinel L Abstract
      Rosacea is a chronic, progressive disease of unknown cause affecting the eye and the facial skin. Ocular rosacea is often underdiagnosed if the ophthalmologist does not inspect the patient's face adequately during the ocular examination. Severe ocular complications and blindness can occur if the treatment is delayed because of non-diagnosis of the rosacea. Here, we present a case of ocular rosacea in a 78-year-old Caucasian woman. Based on the ocular lesions, which preceded cutaneous involvement, she was misdiagnosed as having ocular cicatricial pemphigoid initially. This case emphasizes the difficulty in diagnosis when ocular findings precede those of skin manifestations, and rosacea should be kept in mind in the differential diagnosis of chronic cicatrizing conjunctivitis.
      PMID: 29267579 [PubMed - in process] {url} = URL to article
    • Related Articles Long-pulsed 1064-nm Nd: YAG laser ameliorates LL-37-induced rosacea-like skin lesions through promoting collagen remodeling in BALB/c mice. Lasers Med Sci. 2017 Dec 18;: Authors: Kim M, Kim J, Jeong SW, Jo H, Park HJ Abstract
      Long-pulsed 1064-nm neodymium: yttrium-aluminum-garnet laser (LPND) effectively treats rosacea, although the underlying mechanism is unclear, to evaluate the histological effects and molecular mechanism of LPND on LL-37-induced rosacea-like skin lesions in mice. Intradermal injection of LL-37 was performed into the dorsal skin of BALB/c mice (n = 30) twice a day for 2 days. Fifteen mice were treated with LPND. After 48 h, the excised skin sample was stained for histology and type I collagen; transforming growth factor (TGF)-β, matrix metalloproteinase-1 (MMP-1), tissue inhibitor of metalloproteinase (TIMP)-1, tumor necrosis factor (TNF)-α, and interleukin (IL)-1α mRNA levels were determined by real-time RT-PCR. Intradermal injection of LL-37 induced rosacea-like clinical features. LPND treatment significantly reduced erythema and increased dermal collagen production. Levels of Type I collagen, TGF-β, and MMP-1 mRNA were significantly higher in LPND-treated mice than in untreated mice. LPND may improve rosacea by ameliorating dermal connective tissue disorganization and elastosis through MMP-mediated dermal collagen remodeling.
      PMID: 29256058 [PubMed - as supplied by publisher] {url} = URL to article
    • "While the mites are clearly an extreme case of what can happen if you don't consistently wash your pillowcase, unwashed linens can also lead to other skin conditions like rosacea and acne — and aggravate existing ones." Woman Discovers Over 100 Mites in Eyelashes Because of Unwashed Pillowcase, by Alyssa Hardy, TeenVogue
    • Related Articles [What's new in pediatric dermatology?] Ann Dermatol Venereol. 2017 Dec;144 Suppl 4:IVS29-IVS39 Authors: Chiaverini C Abstract
      The year 2017 in pediatric dermatology was marked by several consensus recommendations and meta analyzes on childhood psoriasis, atopic dermatitis or PHACE syndrome, case series on the role of anti-JAK treatment in adolescent with alopecia areata, sirolimus for vascular malformations, ivermectine for rosacea, inhibitors of MEK for type 1 neurofibromatosis or on the side effects of the oral isotretinoin for acne or propranolol for immature hemangioma. Only few randomized controlled studies have been published on the interest of adalimumab in the treatment of psoriasis or topical sirolimus for angiofibroma in tuberous sclerosis complex for example. There were also clinical articles on various affections such as the sign of the scalp hair collar sign, childhood prurigo, ichthyosis, atopic dermatitis, warts or Zika virus infection. Finally, numerous publications reported new genes responsible for dermatosis in mosaics with new questionings and perspectives.
      PMID: 29249250 [PubMed - in process] {url} = URL to article
    • " For those of you wanting to fend off your rosacea at the cost of an espresso martini or two, read on.....It's [red wine] a vasodilator which causes blood vessels to expand creating redness, plus it releases histamine which again causes redness and flushing. Totally avoid red wine if you struggle with rosacea." 5 Boring But Real Effects Alcohol Has On Your Skin, BY GEORGE DRIVER, Elle
      Which Alcohol is Your Rosacea Trigger?
    • ESKATA™ is the First and Only FDA-Approved Topical, Non-invasive Treatment for Raised SKs MALVERN, Pa., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ESKATA™ (hydrogen peroxide) topical solution, 40% (w/w) for the treatment of raised seborrheic keratoses, or SKs. SKs are non-cancerous skin growths that affect more than 83 million American adults and can be an aesthetic skin concern. SKs tend to increase in size and number with age. The condition is more prevalent than acne, psoriasis and rosacea combined. Aclaris Therapeutics Receives FDA Approval for ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses (SKs), Nasdaq Global Newswire     
    • Related Articles Miscellaneous skin disease and the metabolic syndrome. Clin Dermatol. 2018 Jan - Feb;36(1):94-100 Authors: Seremet S, Gurel MS Abstract
      The link between the metabolic syndrome (MetS) and skin diseases is increasingly important, with new associations being discovered. The association between MetS and psoriasis or MetS and hidradenitis suppurativa is well known, although the relationship between MetS and various autoimmune or inflammatory diseases has only recently attracted interest. Some inflammatory skin diseases, such as vitiligo, scleredema, recurrent aphthous stomatitis, Behçet disease, rosacea, necrobiosis lipoidica, granuloma annulare, skin tags, knuckle pads, and eruptive xanthomas, have possible associations with MetS. In this review, we examine the state of knowledge involving the relationship between MetS and these dermatologic diseases.
      PMID: 29241760 [PubMed - in process] {url} = URL to article
    • Related Articles Reply to: "Rosacea and alcohol intake". J Am Acad Dermatol. 2018 Jan;78(1):e27 Authors: Li S, Drucker AM, Cho E, Qureshi AA, Li WQ PMID: 29241804 [PubMed - in process] {url} = URL to article
    • Given the evidence for an increased risk of GI disease in rosacea, further research into the role of the microbiome in rosacea is warranted. The role of the gut microbiome is an area of research of multiple inflammatory skin diseases. Synbiotics are a combination of prebiotics and probiotics, substances that support a healthy gut microbiome. In a meta-analysis of published randomized controlled trials (RCTs) in atopic dermatitis (AD), it was found that the use of synbiotics for at least eight weeks had a significant effect on a measure of AD severity. Research is underway into the use of synbiotics in other inflammatory skin diseases. Diet and rosacea: the role of dietary change in the management of rosacea.
    • "The association between inflammatory bowel disease (IBD) and rosacea is another topic of interest. A Taiwanese nationwide cohort study of over 89,000 patients with rosacea found an independent association with IBD incidence, as compared to matched controls. This association has been replicated by Egeberg et al.’s Danish study and Li et al.’s prospective study in American women. Moreover, both IBD and rosacea share possible genetic overlap on the histocompatibility complex class II gene HLA DRB1*03:01." Diet and rosacea: the role of dietary change in the management of rosacea.    
    • "Young men with acne have also been studied with respect to their diet. Smith et al recently studied 43 men (15–25 years) with acne who were given instructions to follow a high carbohydrate diet similar to their current diet (control group) compared to a group given instructions to follow a low glycemic load diet for 12 weeks. There was a significant decrease in the number of acne lesions following diet modification in the low glycemic load group compared to the control group." The Role of Diet in Acne and Rosacea
      JCAD Online Editor | September 16, 2008
      by Jonette E. Keri, MD, PhD, and Adena E. Rosenblatt
      Department of Dermatology, University of Miami Miller School of Medicine, Miami, Florida
    • "Ledesma suggested I undergo a micronutrient testing to determine if any supplements could help me to better control my blood sugar and potentially improve my health in other ways. I underwent a blood draw for the SpectraCell Micronutrient Test, a comprehensive test of the biochemical function of vitamins, minerals, amino acids and antioxidants. It seemed like the best way to find out my specific nutritional deficiencies and not take a typical shotgun approach to choosing a wide array of nutrients. The MNT test retails for more than $1,500. I was surprised to find Medicare covered nearly all of it. My cost would be $88. Ledesma said we would balance the nutrients and address any borderline or deficient nutrients." A Patient's Journey: There's a Vitamin for That
      Howard Wolinsky may have the most expensive urine in Chicago, by Howard Wolinsky, Contributing Writer, MedPage Today  
    • "So I went to see the eye doctor. He prescribed an ocular antibiotic. Then, he hit me with a shocker. Out of left field, he diagnosed rosacea of the eyelid. I knew what rosacea was, but had no clue about rosacea of the eyelid. I was stunned to read how it carried a risk of blindness in extreme cases. I continued my Google research and found an academic ophthalmologist in Chicago, Marian Macsai, MD, at NorthShore University HealthSystem, who had researched rosacea of the eyelid. The thought of potential blindness focuses your attention, which is why -- as an ever cautious individual -- I decided to see her. I had to wait a couple months and almost backed out. I'm glad I didn't. Macsai examined my eyes and immediately concluded I didn't have rosacea of the eyelid. Relief. She stopped the antibiotic, which she said was too powerful.....She recommended a non-prescription special blend of fish oil....I ordered the DE, dry-eye blend, and started taking four capsules a day with meals. I suddenly noticed a change. My eyes stopped itching. I seemed fine." A Patient's Journey: There's a Vitamin for That
      Howard Wolinsky may have the most expensive urine in Chicago, by Howard Wolinsky, Contributing Writer, MedPage Today
    • The Latest Drugs and Small Molecule Inhibitors for Skin and Hair. J Drugs Dermatol. 2017 Dec 01;16(12):1224-1228 Authors: Kalhun V, Sadick N Abstract
      <p>Biologic drugs, a novel class of agents engineered to target specifc mediators of infammation, and small-molecule inhibitors that pen-etrate the cell membrane to interact with targets inside a cell represent the cutting-edge of pharmacological biomedical therapeutics. Clinical studies have already demonstrated the effectiveness of this new generation of drugs in treating a variety of medical illnesses and conditions that were refractory to traditional treatments. This review aims to describe the latest available or currently in-develop-ment drugs, biologic agents, and small molecule inhibitors for treatment of psoriasis, rosacea, alopecia areata, and atopic dermatitis. </p> <p><em>J Drugs Dermatol. 2017;16(12):1224-1228</em></p>.
      PMID: 29240857 [PubMed - in process] {url} = URL to article
    • Pityriasis Folliculorum: Response to Topical Ivermectin. J Drugs Dermatol. 2017 Dec 01;16(12):1290-1292 Authors: Darji K, Burkemper NM Abstract
      <p>Pityriasis folliculorum has been described as a dry type of rosacea with extensive proliferation of Demodex folliculorum in pilosebaceous follicles of the skin. This skin condition is frequently difficult to manage, with various treatment options showing mixed efficacy. Oral ivermectin, a macrocyclic lactone parasiticide with anti-inflammatory and anti-parasitic effects, is one of the leading treatment modalities for demodicosis. Topical ivermectin has recently been FDA approved as therapy for rosacea. We present the case of a woman with pityriasis folliculorum who showed significant improvement from using topical ivermectin with no adverse events related to treatment.</p> <p><em>J Drugs Dermatol. 2017;16(12):1290-1292.</em></p>.
      PMID: 29240866 [PubMed - in process] {url} = URL to article
    • Sensitivity happens when your skin’s natural barrier function becomes compromised, allowing irritants to penetrate it. Sensitivity can be caused by genetics and hormonal factors, having overly dry or injured skin, and excessive exposure to damaging environmental factors such as sun, wind and heat. However, a lot of skin irritations can also be self-inflicted. Excessive cleansing with the incorrect products may also trigger skin sensitivity. Exfoliators containing alphahydroxy acid, for example, may overstimulate the skin and cause microscopic cracks that allow toxins and irritants to enter. Typical breakouts that result from skin sensitivity include eczema, rosacea, primary irritant dermatitis, allergic contact dermatitis or dry flakey skin. Ask Ncumisa: What Causes Skin Sensitivity?, Marie Claire
    • A Rosacea Market Report is available ($5750)  that proposed to help in developing business strategies by understanding trends shaping and driving the Rosacea Market. Rosacea Market Research, Growth Opportunities, Analysis and Forecasts Report 2025, MilTech, PR Distribution
×